We are live on
!
Find out more
Madrigal Pharmaceuticals
MDGL
MDGL
148 hedge funds and large institutions have $2.27B invested in Madrigal Pharmaceuticals in 2018 Q2 according to their latest regulatory filings, with 63 funds opening new positions, 47 increasing their positions, 34 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
541% more call options, than puts
Call options by funds: $55.4M | Put options by funds: $8.65M
350% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 14
207% more capital invested
Capital invested by funds: $739M → $2.27B (+$1.53B)
48% more funds holding
Funds holding: 100 → 148 (+48)
38% more repeat investments, than reductions
Existing positions increased: 47 | Existing positions reduced: 34
8.81% more ownership
Funds ownership: 44.46% → 53.27% (+8.8%)
Holders
148
Holders Change
+48
Holders Change %
+48%
% of All Funds
3.39%
Holding in Top 10
6
Holding in Top 10 Change
+6
Holding in Top 10 Change %
% of All Funds
0.14%
New
63
Increased
47
Reduced
34
Closed
14
Calls
$55.4M
Puts
$8.65M
Net Calls
+$46.8M
Net Calls Change
+$46.8M
Top Buyers
Top Sellers
| 1 |
Adage Capital Partners
Boston,
Massachusetts
|
-$35.1M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$31.5M |
| 3 |
Fidelity Investments
Boston,
Massachusetts
|
-$27.6M |
| 4 |
PC
Polar Capital
London,
United Kingdom
|
-$23.4M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$21.1M |
